Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Tongjunge Pharmaceutical is a prominent Chinese pharmaceutical company and a core subsidiary of the Taiji Group, which is now part of the Sinopharm conglomerate. Established in 1908, the company is a recognized China Time-honored Brand specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern pharmaceutical products. Its extensive portfolio includes market-leading treatments for digestive and respiratory ailments, such as Huoxiang Zhengqi Liquid and Jizhi Syrup. The company operates a large-scale manufacturing infrastructure and one of the most extensive retail pharmacy networks in Western China. Tongjunge integrates centuries-old TCM heritage with modern GMP-certified production processes to serve both domestic and international healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tai Chi Group Chongqing Tongjunge Pharmaceutical.